000			01766 a2200505 4500
005			20250516044102.0
264		0	_c20110805
008			201108s 0 0 fre d
022			_a1660-9379
040			_aNLM _beng _cNLM
100	1		_aCarballo, S
245	0	0	_a[Specificities of diabetes in acute coronary syndromes]. _h[electronic resource]
260			_bRevue medicale suisse _cJun 2011
300			_a1200-2, 1204-6 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAcute Coronary Syndrome _xcomplications
650	0	4	_aAlgorithms
650	0	4	_aAngioplasty
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use
650	0	4	_aClopidogrel
650	0	4	_aDiabetes Complications _xdrug therapy
650	0	4	_aDiabetes Mellitus _xdrug therapy
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEnoxaparin _xtherapeutic use
650	0	4	_aEvidence-Based Medicine
650	0	4	_aFibrinolytic Agents _xtherapeutic use
650	0	4	_aHeparin _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aPiperazines _xtherapeutic use
650	0	4	_aPlatelet Aggregation Inhibitors _xtherapeutic use
650	0	4	_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors
650	0	4	_aPrasugrel Hydrochloride
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRisk Factors
650	0	4	_aSecondary Prevention _xmethods
650	0	4	_aStents
650	0	4	_aThiophenes _xtherapeutic use
650	0	4	_aTiclopidine _xanalogs & derivatives
650	0	4	_aTreatment Outcome
700	1		_aCarballo, D
700	1		_aKeller, P F
700	1		_aRoffi, M
773	0		_tRevue medicale suisse _gvol. 7 _gno. 297 _gp. 1200-2, 1204-6
999			_c20970730 _d20970730